WealthSource Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$2.53M Sell
4,332
-532
-11% -$311K 0.16% 99
2023
Q3
$2.61M Sell
4,864
-167
-3% -$86.1K 0.18% 94
2023
Q2
$2.36M Sell
5,031
-62
-1% -$26K 0.16% 102
2023
Q1
$1.75M Buy
5,093
+5
+0.1% +$1.69K 0.12% 139
2022
Q4
$1.86M Sell
5,088
-801
-14% -$284K 0.13% 125
2022
Q3
$1.9M Sell
5,889
-580
-9% -$184K 0.14% 122
2022
Q2
$2.1M Sell
6,469
-1,016
-14% -$305K 0.15% 108
2022
Q1
$2.14M Sell
7,485
-124
-2% -$31.9K 0.14% 116
2021
Q4
$2.1M Sell
7,609
-117
-2% -$29.7K 0.17% 99
2021
Q3
$1.78M Buy
7,726
+1,409
+22% +$348K 0.16% 109
2021
Q2
$1.45M Buy
6,317
+43
+0.7% +$8.64K 0.13% 124
2021
Q1
$1.17M Buy
6,274
+79
+1% +$15.5K 0.12% 135
2020
Q4
$1.05M Sell
6,195
-322
-5% -$48.1K 0.12% 118
2020
Q3
$965K Buy
6,517
+113
+2% +$17.5K 0.13% 101
2020
Q2
$1.05M Buy
6,404
+158
+3% +$24.3K 0.15% 89
2020
Q1
$866K Buy
6,246
+189
+3% +$26K 0.14% 106
2019
Q4
$796K Sell
6,057
-460
-7% -$53.3K 0.1% 164
2019
Q3
$729K Buy
6,517
+1,082
+20% +$120K 0.11% 185
2019
Q2
$602K Buy
+5,435
New +$640K 0.09% 208

Other funds holding LLY

WealthSource Partners's LLY Position: Q4 2023 in Review

WealthSource Partners reduced its Eli Lilly (LLY) stake by 11% in Q4 2023, selling an estimated $311K and leaving 4,332 shares worth $2.53M. The position accounts for 0.16% of the portfolio, ranked #99.

WealthSource Partners first reported a position in LLY in Q2 2019 and has held it in 19 quarters since. The position peaked at $2.61M in Q3 2023. 3,273 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • WealthSource Partners held 4,332 shares of Eli Lilly worth $2.53M as of Q4 2023.
  • WealthSource Partners sold 532 Eli Lilly shares in Q4 2023, an estimated $311K.
  • Eli Lilly made up 0.16% of WealthSource Partners's portfolio in Q4 2023, its #99 holding.
  • WealthSource Partners first reported a position in Eli Lilly in Q2 2019 and has held it in 19 quarters since.
  • WealthSource Partners's Eli Lilly position peaked at $2.61M in Q3 2023.
  • 3,273 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on WealthSource Partners's 13F filing for Q4 2023, filed 16 Jan 2024.